Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 29.27%
March 31, 2026 28.77%
December 31, 2025 28.18%
September 30, 2025 27.66%
June 30, 2025 28.80%
March 31, 2025 28.45%
December 31, 2024 29.19%
September 30, 2024 28.60%
June 30, 2024 29.98%
March 31, 2024 28.65%
December 31, 2023 25.74%
September 30, 2023 27.53%
June 30, 2023 29.63%
March 31, 2023 29.36%
December 31, 2022 25.52%
September 30, 2022 26.32%
June 30, 2022 25.78%
March 31, 2022 24.05%
December 31, 2021 23.21%
September 30, 2021 23.69%
June 30, 2021 26.48%
March 31, 2021 25.94%
December 31, 2020 25.21%
September 30, 2020 24.31%
June 30, 2020 23.33%
Date Value
March 31, 2020 26.56%
December 31, 2019 27.40%
September 30, 2019 26.97%
June 30, 2019 27.96%
March 31, 2019 26.41%
December 31, 2018 25.06%
September 30, 2018 26.00%
June 30, 2018 26.49%
March 31, 2018 23.72%
December 31, 2017 21.06%
September 30, 2017 22.96%
June 30, 2017 26.24%
March 31, 2017 25.68%
December 31, 2016 22.42%
September 30, 2016 22.71%
June 30, 2016 27.16%
March 31, 2016 22.40%
December 31, 2015 26.56%
September 30, 2015 27.61%
June 30, 2015 28.20%
March 31, 2015 25.42%
December 31, 2014 24.42%
September 30, 2014 27.35%
June 30, 2014 27.85%
March 31, 2014 26.09%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 65.92%
Abbott Laboratories 52.64%
AngioDynamics, Inc. 50.87%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%

Gross Profit Margin (Quarterly) Related Metrics